Home » Topics » BioWorld Science

BioWorld Science
RSS

CIRBP as promising biomarker to identify high-risk patients with IPF

Dec. 22, 2021

Alnylam submits CTA in U.K. for ALN-XDH to treat gout

Dec. 22, 2021

R-107 improves multiorgan functioning in a sheep model of sepsis

Dec. 22, 2021

IL-27-producing natural regulatory B-1a cells protect from CNS autoimmune diseases

Dec. 22, 2021

PSMA-targeted docetaxel conjugate with high antitumor activity and improved toxicity and solubility

Dec. 22, 2021

Discovery of novel chalcone derivatives for the treatment of neurodegenerative disorders

Dec. 22, 2021

Discovery of a familial intracranial aneurysm gene

Dec. 22, 2021

OAB-14 restores dysfunction of endosomal-autophagic-lysosomal pathway in APP/PS1 mice

Dec. 22, 2021

CD123 x CD3 bispecific Dart molecule MGD-024 active with other agents in AML models

Dec. 22, 2021

New dihydroorotate dehydrogenase inhibitors described by Medshine Discovery

Dec. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...